Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:

BioSite Launches Triage Stroke Panel In Europe, Defends BNP Test Share

This article was originally published in The Gray Sheet

  • News

Executive Summary

BioSite's European launch of its Triage stroke panel comes as the firm faces increasing BNP test pricing pressure from Abbott Labs

You may also be interested in...



AACC Speakers Seek Cost-Efficient Cardiac Biomarker Panel

Healthcare cost pressures appear to be shifting the burden of stratifying potential acute coronary syndrome patients to earlier in the hospitalization process

AACC Speakers Seek Cost-Efficient Cardiac Biomarker Panel

Healthcare cost pressures appear to be shifting the burden of stratifying potential acute coronary syndrome patients to earlier in the hospitalization process

Cardiac Markers Clash For Hospital, Lab Space: Biosite Triages R&D Projects

Biosite's pursuit of additional disease markers for its Triage immunoassay meter will continue unabated this summer, even as the company defends BNP test market share from newcomer Abbott Labs and imminent rival Dade Behring

Table

View full table

Tags:
Latest Headlines

GE HealthCare Launches AI-Powered Voluson Ultrasound For Women’s Health

FDA’s New Dataset Aims To Assist Labs In Assessing Medical Device Biocompatibility

‘Core Pillars’ Of Safety And Innovation Take Center Stage In FDA Reports

Lilly Can Rest Easy As Tirzepatide Scores Phase III Sleep Apnea Win

See All
UsernamePublicRestriction

Register

MT022450

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By